Quest Diagnostics Incorporated Pricing of Senior Notes Offering

Quest Diagnostics Incorporated announced on April 27, 2026, the pricing of a public offering of $500 million in aggregate principal amount of 5.000% senior notes due 2036. The offering is being conducted under the Company's shelf registration statement. The net proceeds from the offering are intended for general corporate purposes, which may include the repayment of existing indebtedness. Notably, the Company may use these proceeds to repay its $500 million aggregate principal amount of 3.45% Senior Notes maturing on June 1, 2026. The closing of the offering is expected on May 6, 2026, subject to customary conditions. In conjunction with the offering, the Company entered into an underwriting agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Mizuho Securities USA LLC, acting as representatives for the underwriters.